Corrigendum to "PCIF1-mediated m6Am modification activates USP5/BRD4 Axis to promote glycolysis-driven immunosuppression in multiple myeloma" [Int. Immunopharmacol. 186 (2026), 117062].
- DOI
- 10.1016/j.intimp.2026.117449
- Published
- 2026 Sep 26
- Container
- International immunopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117449,
title = {Corrigendum to "PCIF1-mediated m6Am modification activates USP5/BRD4 Axis to promote glycolysis-driven immunosuppression in multiple myeloma" [Int. Immunopharmacol. 186 (2026), 117062].},
author = {Long S and Ding T and Zhou L and Gao W and Wang Q and Liu Y},
year = {2026},
journal = {International immunopharmacology},
doi = {10.1016/j.intimp.2026.117449},
url = {https://doi.org/10.1016/j.intimp.2026.117449}
}RIS
TY - JOUR TI - Corrigendum to "PCIF1-mediated m6Am modification activates USP5/BRD4 Axis to promote glycolysis-driven immunosuppression in multiple myeloma" [Int. Immunopharmacol. 186 (2026), 117062]. AU - Long S AU - Ding T AU - Zhou L AU - Gao W AU - Wang Q AU - Liu Y PY - 2026 JO - International immunopharmacology DO - 10.1016/j.intimp.2026.117449 UR - https://doi.org/10.1016/j.intimp.2026.117449 ER -
APA
S, L., T, D., L, Z., W, G., Q, W., & Y, L. (2026). Corrigendum to "PCIF1-mediated m6Am modification activates USP5/BRD4 Axis to promote glycolysis-driven immunosuppression in multiple myeloma" [Int. Immunopharmacol. 186 (2026), 117062].. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117449
Source records
- pubmed · retrieved 2026-09-27T07:33:53.329Z